CA2005061A1 - Peptides tnf - Google Patents

Peptides tnf

Info

Publication number
CA2005061A1
CA2005061A1 CA002005061A CA2005061A CA2005061A1 CA 2005061 A1 CA2005061 A1 CA 2005061A1 CA 002005061 A CA002005061 A CA 002005061A CA 2005061 A CA2005061 A CA 2005061A CA 2005061 A1 CA2005061 A1 CA 2005061A1
Authority
CA
Canada
Prior art keywords
peptide
gly
thr
amino
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002005061A
Other languages
English (en)
Inventor
Hans-Joachim Boehm
Lothar Daum
Andreas Haupt
Bernhard Schmied
Nigel Walker
Johann-Christian Zechel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of CA2005061A1 publication Critical patent/CA2005061A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002005061A 1988-12-12 1989-12-11 Peptides tnf Abandoned CA2005061A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3841762A DE3841762A1 (de) 1988-12-12 1988-12-12 Neue tnf-peptide
DEP3841762.6 1988-12-12

Publications (1)

Publication Number Publication Date
CA2005061A1 true CA2005061A1 (fr) 1990-06-12

Family

ID=6368957

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005061A Abandoned CA2005061A1 (fr) 1988-12-12 1989-12-11 Peptides tnf

Country Status (5)

Country Link
EP (1) EP0449915A1 (fr)
JP (1) JPH04502154A (fr)
CA (1) CA2005061A1 (fr)
DE (1) DE3841762A1 (fr)
WO (1) WO1990006940A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587457A (en) * 1990-03-12 1996-12-24 Peptide Technology Limited Neutrophil stimulating peptides
US6375928B1 (en) 1990-03-12 2002-04-23 Peptech Limited Neutrophil stimulating peptides

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006658A2 (fr) * 1989-10-24 1991-05-16 Cetus Corporation Systeme d'apport de proteines infectieuses
AU8337291A (en) * 1990-08-06 1992-03-02 Cetus Corporation Methods for the identification of cytokine convertase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190127A1 (fr) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Agents polypeptides immunotherapeutiques

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587457A (en) * 1990-03-12 1996-12-24 Peptide Technology Limited Neutrophil stimulating peptides
US6375928B1 (en) 1990-03-12 2002-04-23 Peptech Limited Neutrophil stimulating peptides

Also Published As

Publication number Publication date
WO1990006940A1 (fr) 1990-06-28
DE3841762A1 (de) 1990-06-13
EP0449915A1 (fr) 1991-10-09
JPH04502154A (ja) 1992-04-16

Similar Documents

Publication Publication Date Title
SI9300661A (en) Novel peptides with antineoplastic effect, the preparation and use thereof
HU210566B (en) Process for preparing bradykinin antagonist peptides and pharmaceutical preparations containing them
CA2112907C (fr) Peptide eliminant la toxicite du tnf et/ou du lps
KR100286242B1 (ko) 돌라스타틴 유도체
CA2005058A1 (fr) Peptides tnf
CA2005059A1 (fr) Peptides tnf
CA2005051A1 (fr) Peptides tnf
US20240209023A1 (en) Peptide compound, application thereof and composition containing same
US4473555A (en) Nona- and dodecapeptides for augmenting natural killer cell activity
CA2005050A1 (fr) Peptides tnf
CA2005060A1 (fr) Peptides tnf
CA2005061A1 (fr) Peptides tnf
CA2005281A1 (fr) Peptides tnf
CA2005052A1 (fr) Peptides tnf
US5393873A (en) Peptides with anticoagulant activity
CA2005056A1 (fr) Peptides tnf
CA2005057A1 (fr) Peptides tnf
AU642487B2 (en) Neutrophil stimulating peptides
WO1993006128A1 (fr) Peptides antagonistes du facteur de necrose tumorale
WO2002068457A2 (fr) Peptides antiangiogeniques
WO1992011285A1 (fr) Nouveaux peptides constituant des facteurs de necrose tumorale

Legal Events

Date Code Title Description
FZDE Dead